SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson

Detalhes bibliográficos
Autor(a) principal: Santos, Gesivaldo
Data de Publicação: 2016
Outros Autores: Giraldez-Alvarez, Lisandro Diego, Avila-Rodriguez, Marco, Capani, Francisco, Galembeck, Eduardo [UNESP], Neto, Aristoteles Goes, Barreto, George E., Andrade, Bruno
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.3389/fnagi.2016.00097
http://hdl.handle.net/11449/158846
Resumo: Parkinson's disease (PD) is one of the most common neurodegenerative disorders. A theoretical approach of our previous experiments reporting the cytoprotective effects of the Valeriana officinalis compounds extract for PD is suggested. In addiction to considering the PD as a result of mitochondrial metabolic imbalance and oxidative stress, such as in our previous in vitro model of rotenone, in the present manuscript we added a genomic approach to evaluate the possible underlying mechanisms of the effect of the plant extract. Microarray of substantia nigra (SN) genome obtained from Allen Brain Institute was analyzed using gene set enrichment analysis to build a network of hub genes implicated in PD. Proteins transcribed from hub genes and their ligands selected by search ensemble approach algorithm were subjected to molecular docking studies, as well as 20 ns Molecular Dynamics (MD) using a Molecular Mechanic Poison/Boltzman Surface Area (MMPBSA) protocol. Our results bring a new approach to Valeriana officinalis extract, and suggest that hesperidin, and probably linarin are able to relieve effects of oxidative stress during ATP depletion due to its ability to binding SUR1. In addition, the key role of valerenic acid and apigenin is possibly related to prevent cortical hyperexcitation by inducing neuronal cells from SN to release GABA on brain stem. Thus, under hyperexcitability, oxidative stress, asphyxia and/or ATP depletion, Valeriana officinalis may trigger different mechanisms to provide neuronal cell protection.
id UNSP_9eaa5f9481e32117808f5f325c2ae881
oai_identifier_str oai:repositorio.unesp.br:11449/158846
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in ParkinsonValeriana officinalisParkinson diseaseneuroprotectionSUR1GABAAParkinson's disease (PD) is one of the most common neurodegenerative disorders. A theoretical approach of our previous experiments reporting the cytoprotective effects of the Valeriana officinalis compounds extract for PD is suggested. In addiction to considering the PD as a result of mitochondrial metabolic imbalance and oxidative stress, such as in our previous in vitro model of rotenone, in the present manuscript we added a genomic approach to evaluate the possible underlying mechanisms of the effect of the plant extract. Microarray of substantia nigra (SN) genome obtained from Allen Brain Institute was analyzed using gene set enrichment analysis to build a network of hub genes implicated in PD. Proteins transcribed from hub genes and their ligands selected by search ensemble approach algorithm were subjected to molecular docking studies, as well as 20 ns Molecular Dynamics (MD) using a Molecular Mechanic Poison/Boltzman Surface Area (MMPBSA) protocol. Our results bring a new approach to Valeriana officinalis extract, and suggest that hesperidin, and probably linarin are able to relieve effects of oxidative stress during ATP depletion due to its ability to binding SUR1. In addition, the key role of valerenic acid and apigenin is possibly related to prevent cortical hyperexcitation by inducing neuronal cells from SN to release GABA on brain stem. Thus, under hyperexcitability, oxidative stress, asphyxia and/or ATP depletion, Valeriana officinalis may trigger different mechanisms to provide neuronal cell protection.Universidade Estadual do Sudoeste da BahiaPontificia Universidad JaverianaJovenes Investigadores (Colciencias)Univ Estadual Sudoeste Bahia, Dept Ciencias Biol, Jequie, BrazilUniv Estadual Sudoeste Bahia, Dept Quim & Exatas, PNPD CAPES, Jequie, BrazilPontificia Univ Javeriana, Fac Ciencias, Dept Nutr & Bioquim, Bogota, DC, ColombiaUBA CONICET, Inst Invest Cardiol Prof Dr Alberto C Taquini INI, Buenos Aires, DF, ArgentinaUniv Estadual Paulista, Inst Biol, Dept Bioquim, Campinas, SP, BrazilUniv Fed Estadual Feira Santana, Dept Ciencias Biol, Feira De Santana, BrazilUniv Autonoma Chile, Inst Ciencias Biomed, Santiago, ChileUniv Cient Sur, Lima, PeruUniv Estadual Paulista, Inst Biol, Dept Bioquim, Campinas, SP, BrazilPontificia Universidad Javeriana: 5575Pontificia Universidad Javeriana: 5024Jovenes Investigadores (Colciencias): 6027Frontiers Media SaUniv Estadual Sudoeste BahiaPontificia Univ JaverianaUBA CONICETUniversidade Estadual Paulista (Unesp)Univ Fed Estadual Feira SantanaUniv Autonoma ChileUniv Cient SurSantos, GesivaldoGiraldez-Alvarez, Lisandro DiegoAvila-Rodriguez, MarcoCapani, FranciscoGalembeck, Eduardo [UNESP]Neto, Aristoteles GoesBarreto, George E.Andrade, Bruno2018-11-26T15:29:25Z2018-11-26T15:29:25Z2016-05-02info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article12application/pdfhttp://dx.doi.org/10.3389/fnagi.2016.00097Frontiers In Aging Neuroscience. Lausanne: Frontiers Media Sa, v. 8, 12 p., 2016.1663-4365http://hdl.handle.net/11449/15884610.3389/fnagi.2016.00097WOS:000375647800001WOS:000375647800001.pdfWeb of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengFrontiers In Aging Neuroscience1,638info:eu-repo/semantics/openAccess2023-10-26T06:08:29Zoai:repositorio.unesp.br:11449/158846Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462024-08-05T16:02:04.900601Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson
title SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson
spellingShingle SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson
Santos, Gesivaldo
Valeriana officinalis
Parkinson disease
neuroprotection
SUR1
GABAA
title_short SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson
title_full SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson
title_fullStr SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson
title_full_unstemmed SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson
title_sort SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson
author Santos, Gesivaldo
author_facet Santos, Gesivaldo
Giraldez-Alvarez, Lisandro Diego
Avila-Rodriguez, Marco
Capani, Francisco
Galembeck, Eduardo [UNESP]
Neto, Aristoteles Goes
Barreto, George E.
Andrade, Bruno
author_role author
author2 Giraldez-Alvarez, Lisandro Diego
Avila-Rodriguez, Marco
Capani, Francisco
Galembeck, Eduardo [UNESP]
Neto, Aristoteles Goes
Barreto, George E.
Andrade, Bruno
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Univ Estadual Sudoeste Bahia
Pontificia Univ Javeriana
UBA CONICET
Universidade Estadual Paulista (Unesp)
Univ Fed Estadual Feira Santana
Univ Autonoma Chile
Univ Cient Sur
dc.contributor.author.fl_str_mv Santos, Gesivaldo
Giraldez-Alvarez, Lisandro Diego
Avila-Rodriguez, Marco
Capani, Francisco
Galembeck, Eduardo [UNESP]
Neto, Aristoteles Goes
Barreto, George E.
Andrade, Bruno
dc.subject.por.fl_str_mv Valeriana officinalis
Parkinson disease
neuroprotection
SUR1
GABAA
topic Valeriana officinalis
Parkinson disease
neuroprotection
SUR1
GABAA
description Parkinson's disease (PD) is one of the most common neurodegenerative disorders. A theoretical approach of our previous experiments reporting the cytoprotective effects of the Valeriana officinalis compounds extract for PD is suggested. In addiction to considering the PD as a result of mitochondrial metabolic imbalance and oxidative stress, such as in our previous in vitro model of rotenone, in the present manuscript we added a genomic approach to evaluate the possible underlying mechanisms of the effect of the plant extract. Microarray of substantia nigra (SN) genome obtained from Allen Brain Institute was analyzed using gene set enrichment analysis to build a network of hub genes implicated in PD. Proteins transcribed from hub genes and their ligands selected by search ensemble approach algorithm were subjected to molecular docking studies, as well as 20 ns Molecular Dynamics (MD) using a Molecular Mechanic Poison/Boltzman Surface Area (MMPBSA) protocol. Our results bring a new approach to Valeriana officinalis extract, and suggest that hesperidin, and probably linarin are able to relieve effects of oxidative stress during ATP depletion due to its ability to binding SUR1. In addition, the key role of valerenic acid and apigenin is possibly related to prevent cortical hyperexcitation by inducing neuronal cells from SN to release GABA on brain stem. Thus, under hyperexcitability, oxidative stress, asphyxia and/or ATP depletion, Valeriana officinalis may trigger different mechanisms to provide neuronal cell protection.
publishDate 2016
dc.date.none.fl_str_mv 2016-05-02
2018-11-26T15:29:25Z
2018-11-26T15:29:25Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.3389/fnagi.2016.00097
Frontiers In Aging Neuroscience. Lausanne: Frontiers Media Sa, v. 8, 12 p., 2016.
1663-4365
http://hdl.handle.net/11449/158846
10.3389/fnagi.2016.00097
WOS:000375647800001
WOS:000375647800001.pdf
url http://dx.doi.org/10.3389/fnagi.2016.00097
http://hdl.handle.net/11449/158846
identifier_str_mv Frontiers In Aging Neuroscience. Lausanne: Frontiers Media Sa, v. 8, 12 p., 2016.
1663-4365
10.3389/fnagi.2016.00097
WOS:000375647800001
WOS:000375647800001.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Frontiers In Aging Neuroscience
1,638
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 12
application/pdf
dc.publisher.none.fl_str_mv Frontiers Media Sa
publisher.none.fl_str_mv Frontiers Media Sa
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1808128597188149248